Ultrahuman, the Bengaluru-based wearable healthtech company behind the Ultrahuman Ring, has raised ₹400 crore in a Series C funding round to accelerate its global expansion, enhance product development, and scale manufacturing. The round will support entry into new international markets, launch of advanced wearables, deeper AI personalization features, and strengthening of its ecosystem for preventive and performance health.
Glimpse:
The ₹400 crore Series C, led by prominent global and Indian investors, will enable Ultrahuman to expand distribution in the U.S., Europe, and Southeast Asia, accelerate R&D for next-gen rings and health wearables, boost AI-driven Biointelligence capabilities for real-time insights, and ramp up production capacity in India. The funding comes amid strong growth in the wearable health market, with Ultrahuman targeting millions more users through premium, subscription-free features focused on sleep, recovery, metabolic health, and cognitive performance.
Ultrahuman, the innovative Bengaluru-based healthtech company renowned for its AI-powered Ultrahuman Ring, has successfully closed a ₹400 crore Series C funding round. The investment, announced on February 27, 2026, was led by a mix of global institutional investors and prominent Indian funds with strong participation from strategic angels. This latest round brings Ultrahuman’s total funding to over ₹1,000 crore and arrives at a pivotal moment as the company transitions from early adopter success in India to a truly global player in the premium wearable health market.
The fresh capital will primarily fuel Ultrahuman’s international expansion, with targeted launches and distribution build-out in key markets including the United States, Europe, Southeast Asia, and the Middle East. The company will invest heavily in localized marketing, regulatory clearances (FDA, CE Mark), and supply chain partnerships to make its products more widely available. Funds will also accelerate R&D for next-generation wearables, including enhanced sensor suites, longer battery life, and deeper integration of the Biointelligence AI engine for real-time, proactive health recommendations around sleep optimization, stress regulation, metabolic health, recovery tracking, and cognitive performance.
Ultrahuman’s leadership highlighted that the funding will support manufacturing scale-up in India to meet rising global demand while maintaining cost competitiveness and quality. The company plans to expand its ecosystem through strategic collaborations with hospitals, sports teams, corporate wellness programs, and insurers to embed Ultrahuman devices in preventive health and performance tracking initiatives. The platform’s subscription-free core features, combined with optional premium coaching, have already driven strong user retention and engagement, particularly among professionals, athletes, and health-conscious consumers seeking actionable insights without ongoing fees.
The Series C reflects surging investor confidence in India’s wearable and healthtech sector, where Ultrahuman has emerged as a leader by focusing on science-backed, personalized wellness rather than generic fitness tracking. The company has already shipped tens of thousands of Rings globally and seen rapid adoption in markets like the U.S. and UAE, with strong word-of-mouth growth driven by its accuracy in sleep staging, HRV analysis, and recovery scoring. The new funding positions Ultrahuman to compete more aggressively with global giants while continuing to innovate in areas like circadian alignment, metabolic insights, and neurofeedback-inspired features.
This round is expected to propel Ultrahuman toward profitability and market leadership in the premium wearable segment, while contributing to India’s growing reputation as a hub for innovative consumer health technologies. The company plans to launch several new products and features in the coming 12–18 months, further solidifying its role in preventive and performance health.
“Wearables are evolving from trackers to intelligent health companions. With this funding, we’re accelerating our mission to bring personalized, proactive wellness to millions worldwide starting right here in India and going global.”
By
HB Team
